Janssen announces FDA approval of Stelara for plaque psoriasis
The FDA has approved an expanded indication for Stelara for the treatment of adolescents with moderate plaque psoriasis...
List view / Grid view
News
Experimental Ebola vaccines elicit year-long immune response
Clinical trial results show that two candidate Ebola vaccines can elicit immune responses after initial vaccination that last for at least one year...
Experimental nano-chemo particle to treat bladder cancer
Researchers have developed a way to successfully deliver nano-sized, platinum-based chemotherapy drugs to treat a form of bladder cancer...
NIH launches $215m partnership for cancer immunotherapy strategies
The NIH and 11 leading biopharmaceutical companies have launched the Partnership for Accelerating Cancer Therapies (PACT), totalling $215m as part of the Cancer Moonshot....
PI3K inhibitors show hope for rare bone cancers
Scientists have used genome sequencing to gain a better understanding of the biology underlying chordoma...
Polyphor launches the development of an inhaled antibiotic murepavadin
Polyphor Ltd has announced €5m funding, in order to support and accelerate the development of an inhaled dosage form of murepavadin...
Rapamycin treatment prevents crippling heterotopic ossification
FDA-approved drug holds promise for first effective treatment to prevent trauma-induced heterotopic ossification formation...
Neratinib defeats the Ras genes notorious for causing cancer
Breast cancer drug neratinib has been found to block the function of the Ras genes which are among the first to be linked to cancer development...
Join Dolomite Bio at ASHG 2017
Dolomite Bio is set to display its innovative range of products for high throughput single cell research at the 67th Annual Meeting of the American Society of Human Genetics (ASHG), taking place at the Orange County Convention Center in Orlando, Florida, from the 17th to the 21st of October 2017...
Researchers discover new targets for approved cancer drug ceritinib
New study shows ALK inhibitor ceritinib may have the ability to be used for more than ALK-rearranged non-small cell lung cancer...
ANSM grants authorisation for phase I/II clinical study for retinitis pigmentosa
The French National Agency for Medicines and Health Products Safety is set to launch a Phase I/II clinical trial for HORA-PDE6B, in the treatment of a retinitis pigmentosa...
Ibuprofen better choice over oral morphine for pain relief in children
Widely available ibuprofen is a better choice for pain relief in children who have undergone minor surgery, as it has fewer adverse effects compared with oral morphine...
Topical treatment strategy for fighting skin cancer identified
Researchers have combined low-intensity electric current with a formulation containing nano-encapsulated chemotherapy to treat skin cancer...
Common acid reflux medications promote chronic liver disease
Researchers have discovered evidence that stomach acid suppression alters specific gut bacteria in a way that promotes liver injury and progression of three types of chronic liver disease...
Horiba Scientific introduces new clue series detectors for scanning electron microscopes
HORIBA CLUE Series offer a scalable platform for imaging and spectroscopic analysis of nano-objects with SEM and dual SEM/FIB (Focused Ion Beam) microscopes...
